On lust and rage–prostate cancer, vasectomy and virility in the aging male

References

• Foster R F. WB Yeats: A life. Volume 2: II The arch poet 1915–1939. OUP, Oxford 2003
   Google Scholar
• Benjamin H. The effects of vasectomy (Steinach's operation). Am Med 1922; 28: 435–443
   Google Scholar
• Huggins C, Hodges C V. Studies on prostatic cancer: 1. The effect of castration, of estrogen and of androgen injection on serum phosphotases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293–297
   Google Scholar
• Nesbit R M, Baum W C. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. JAMA 1950; 143: 1317–1320
   PubMed Web of Science ®Google Scholar
• Wolfers D, Wolfers H. Vasectomania. Fam Plann Perspect 1973; 5: 196–199
   PubMedGoogle Scholar
• Giovannucci E, Tosteson T D, Speizer F E, Ascherio A, Vessey M P, Colditz G A. A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993; 269: 878–882
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Ascherio A, Rimm E B, Colditz G A, Stampfer M J, Willett W C. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993; 269: 873–837
   PubMed Web of Science ®Google Scholar
• Mo Z N, Huang X, Zhang S C, Yang J R. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels. J Urol 1995; 154: 2065–2069
   PubMed Web of Science ®Google Scholar
• Dennis L K, Dawson D V, Resnick M I. Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer Prostatic Dis 2002; 5: 193
   PubMed Web of Science ®Google Scholar
• Morgentaler A. Testosterone and prostate cancer: An historical perspective on a modern myth. Eur Urol 2006; 50: 935–939
   PubMed Web of Science ®Google Scholar
• Eaton N E, Reeves G K, Appleby P N, Key T J. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 1999; 80: 930–934
   PubMed Web of Science ®Google Scholar
• Emmelot-Vonk M H, Verhaar H J, Nakhai Pour H R, Aleman A, Lock T M, Bosch J L, Grobbee D E, van der Schouw Y T. Effect of Testosterone supplementation on functional morbidity, cognition and other parameters in older men. JAMA 2008; 299: 39–52
   PubMed Web of Science ®Google Scholar
• Morgentaler A. Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship. Eur Urol 2007; 52: 623–625
   PubMed Web of Science ®Google Scholar
• San Francisco I F, Regan M M, Dewolf W C, Olumo A F. Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. J Urol 2006; 175: 1341–1345
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Kaufman J M, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002; 5: 98–102
   PubMedGoogle Scholar
• Cook L S, Goldoft M, Schwartz S M, Weiss N S. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999; 161: 152–155
   PubMed Web of Science ®Google Scholar
• Sim H G, Cheng C W. Changing demography of prostate cancer in Asia. Eur J Cancer 2005; 41: 834–845
   PubMed Web of Science ®Google Scholar
• Coffey D S. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology 2001; 57(4 Suppl. 1)31–38
   PubMed Web of Science ®Google Scholar
• Rohrmann S, Roberts W W, Walsh P C, Platz E A. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 2003; 55: 140–146
   PubMed Web of Science ®Google Scholar
• Carruba G. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 2007; 102: 899–911
   PubMed Web of Science ®Google Scholar
• Higgins B, Thompson I M. The prostate cancer prevention trial: current status. J Urol 2004; 171: S15–S18
   PubMedGoogle Scholar
• Risbridger G P, Bianco J J, Ellem S J, McPherson S J. Oestrogens and prostate cancer. Endocr Relat Cancer 2003; 10: 87–91
   Web of Science ®Google Scholar
• Weihua Z, Makela S, Andersson L C, Salmi S, Saji S, Webster J I, Jensen E V, Nilsson S, Warner M, Gustafsson J A. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001; 98: 6330–6335
   PubMed Web of Science ®Google Scholar
• Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004; 11: 537–551
   PubMed Web of Science ®Google Scholar
• Pitts W R, Jr. Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromatase. Br J Urol Int 2007; 100: 254–257
   Google Scholar
• Ho S M, Yuet-Kin L, Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann NY Acad Sci 2006; 1089: 177–193
   PubMed Web of Science ®Google Scholar